Metastatic bone disease: Diagnosis, evaluation, and treatment

Journal of Bone and Joint Surgery

Volumn 91, Issue 6, 2009, Pages 1518-1530

  Biermann, J Sybil ^a   Holt, Ginger E ^b   Lewis, Valerae O ^c   Schwartz, Herbert S ^b   Yaszemski, Michael J ^d  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b Medical Center East   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BONE CEMENT; POLY(METHYL METHACRYLATE);

ARTHROPLASTY; AUTOGRAFT; BENIGN TUMOR; BONE GRAFT; BONE LESION; BONE METASTASIS; BONE PROSTHESIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; BONE SCREW; BONE TUMOR; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CEMENTOPLASTY; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FAT EMBOLISM; FOLLOW UP; FRACTURE HEALING; HISTOPATHOLOGY; HUMAN; HYPOTENSION; IMPLANT; INTRAMEDULLARY NAILING; LIFE EXPECTANCY; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; METASTASIS; MINIMALLY INVASIVE PROCEDURE; MULTIPLE MYELOMA; MUSCULOSKELETAL PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN REDUCTION; OSTEOSARCOMA; OSTEOSYNTHESIS; PATHOLOGIC FRACTURE; PERCUTANEOUS VERTEBROPLASTY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SPINAL CORD COMPRESSION; SPINAL CORD METASTASIS; SPINE METASTASIS; TREATMENT FAILURE; TREATMENT INDICATION; TUMOR LOCALIZATION; TUMOR VOLUME; WHOLE BODY SCINTISCANNING; CANCER INVASION; FEMALE; MALE; METHODOLOGY; MORTALITY; PALLIATIVE THERAPY; PATHOLOGY; PATIENT SELECTION; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

BONE NEOPLASMS; FEMALE; FRACTURE FIXATION, INTERNAL; FRACTURE FIXATION, INTRAMEDULLARY; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PALLIATIVE CARE; PATIENT SELECTION; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 67649882184     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Schulman KL, Kohles J. Economic burden of metastatic bone disease in the U.S. Cancer. 2007;109:2334-2342 (Pubitemid 46801565)
2. American Cancer Society. Cancer facts and figures. 2006. http://www.cancer.org/docroot/STT/stt-0-2006.asp?sitearea=STT&level=1.
3. Bagi CM. Targeting of therapeutic agents to bone to treat metastatic cancer. Adv Drug Deliv Rev. 2005;57:995-1010.
4. Oien KA, Evans TR. Raising the profile of cancer of unknown primary. J Clin Oncol. 2008;26:4373-4375
5. Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer. 2004;100:1776-1785 (Pubitemid 38529553)
6. Simon MA, Finn HA. Diagnostic strategy for bone and soft-tissue tumors. J Bone Joint Surg Am. 1993;75:622-631
7. Rougraff BT, Kneisl JS, Simon MA. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. J Bone Joint Surg Am. 1993;75:1276-1281
8. Ambrosini V, Nanni C, Rubello D, Moretti A, Battista G, Castellucci P, Farsad M, Rampin L, Fiorentini G, Franchi R, Canini R, Fanti S. 18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin. Radiol Med. 2006;111:1146-1155 (Pubitemid 46024906)
9. Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M, Bisi G. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site. Q J Nucl Med Mol Imaging. 2006;50:15-22.
10. Scott CL, Kudaba I, Stewart JM, Hicks RJ, Rischin D. The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin. Mol Imaging Biol. 2005;7:236-243 (Pubitemid 41348866)
11. Nathan SS, Healey JH, Mellano D, Hoang B, Lewis I, Morris CD, Athanasian EA, Boland PJ. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol. 2005;23:6072-6082 (Pubitemid 46300225)
12. Bohm P, Huber J. The surgical treatment of bony metastases of the spine and limbs. J Bone Joint Surg Br. 2002;84:521-529 (Pubitemid 34578501)
13. Kelly CM, Wilkins RM, Eckardt JJ, Ward WG. Treatment of metastatic disease of the tibia. Clin Orthop Relat Res. 2003;415 Suppl:S219-29.
14. Damron TA. Treatment principles and prediction of the impending pathologic fracture. In: Schwartz HS, editor. Orthopaedic knowledge update: musculoskeletal tumors 2. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2007. p 369-374
15. Ogilvie CM, Fox EJ, Lackman RD. Current surgical management of bone metastases in the extremities and pelvis. Semin Oncol. 2008;35:118-128
16. Sim FH, Daugherty TW, Ivins JC. The adjunctive use of methylmethacrylate in fixation of pathological fractures. J Bone Joint Surg Am. 1974;56:40-48
17. Weber KL, Randall RL, Grossman S, Parvizi J. Management of lower-extremity bone metastasis. J Bone Joint Surg Am. 2006;88 Suppl 4:11-19
18. Gainor BJ, Buchert P. Fracture healing in metastatic bone disease. Clin Orthop Relat Res. 1983;178:297-302.
19. Frassica DA. General principles of external beam radiation therapy for skeletal metastases. Clin Orthop Relat Res. 2003;415 Suppl:S158-64.
20. Townsend PW, Smalley SR, Cozad SC, Rosenthal HG, Hassanein RE. Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. Int J Radiat Oncol Biol Phys. 1995;31:43-49
21. Frassica FJ, Frassica DA. Evaluation and treatment of metastases to the humerus. Clin Orthop Relat Res. 2003;415 Suppl:S212-8.
22. Damron TA, Rock MG, Choudhury SN, Grabowski JJ, An KN. Biomechanical analysis of prophylactic fixation for middle third humeral impending pathologic fractures. Clin Orthop Relat Res. 1999;363:240-248
23. Weber KL, Lewis VO, Randall RL, Lee AK, Springfield D. An approach to the management of the patient with metastatic bone disease. Instr Course Lect. 2004;53:663-676
24. Marco RA, Sheth DS, Boland PJ, Wunder JS, Siegel JA, Healey JH. Functional and oncological outcome of acetabular reconstruction for the treatment of metastatic disease. J Bone Joint Surg Am. 2000;82:642-651 (Pubitemid 30307866)
25. Harrington KD. New trends in the management of lower extremity metastases. Clin Orthop Relat Res. 1982;169:53-61.
26. Wunder JS, Ferguson PC, Griffin AM, Pressman A, Bell RS. Acetabular metastases: planning for reconstruction and review of results. Clin Orthop Relat Res. 2003;415 Suppl:S187-97.
27. Harrington KD. The management of acetabular insufficiency secondary to metastatic malignant disease. J Bone Joint Surg Am. 1981;63:653-664 (Pubitemid 11090626)
28. Camnasio F, Scotti C, Peretti GM, Fontana F, Fraschini G. Prosthetic joint replacement for long bone metastases: analysis of 154 cases. Arch Orthop Trauma Surg. 2008;128:787-793
29. Herrenbruck T, Erickson EW, Damron TA, Heiner J. Adverse clinical events during cemented long-stem femoral arthroplasty. Clin Orthop Relat Res. 2002;395:154-163 (Pubitemid 34136667)
30. Simon CJ, Dupuy DE. Percutaneous minimally invasive therapies in the treatment of bone tumors: thermal ablation. Semin Musculoskelet Radiol. 2006;10:137-144 (Pubitemid 43787714)
31. de Baere T, Bessoud B, Dromain C, Ducreux M, Boige V, Lassau N, Smayra T, Girish BV, Roche A, Elias D. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol. 2002;178:53-59 (Pubitemid 34016370)
32. de Baere T, Kuoch V, Smayra T, Dromain C, Cabrera T, Court B, Roche A. Radio frequency ablation of renal cell carcinoma: preliminary clinical experience. J Urol. 2002;167:1961-1964 (Pubitemid 34309636)
33. de Baère T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, Gamal El Din M, Letoublon C, Elias D. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol. 2003;181:695-700. (Pubitemid 37021837)
34. Belhassen B, Rogowski O, Glick A, Viskin S, Ilan M, Rosso R, Eldar M. Radiofrequency ablation of accessory pathways: a 14 year experience at the Tel Aviv Medical Center in 508 patients. Isr Med Assoc J. 2007;9:265-270 (Pubitemid 46692042)
35. Topilski I, Rogowski O, Glick A, Viskin S, Eldar M, Belhassen B. Radiofrequency ablation of atrioventricular nodal reentry tachycardia: a 14 year experience with 901 patients at the Tel Aviv Sourasky Medical Center. Isr Med Assoc J. 2006;8:455-459 (Pubitemid 44122022)
36. Steinke K. Radiofrequency ablation of pulmonary tumours: current status. Cancer Imaging. 2008;8:27-35.
37. Steinke K, Sewell PE, Dupuy D, Lencioni R, Helmberger T, Kee ST, Jacob AL, Glenn DW, King J, Morris DL. Pulmonary radiofrequency ablation - an international study survey. Anticancer Res. 2004;24:339-343 (Pubitemid 38279729)
38. Zhu JC, Yan TD, Morris DL. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol. 2008;15:1765-1774
39. Simon CJ, Dupuy DE, DiPetrillo TA, Safran HP, Grieco CA, Ng T, Mayo-Smith WW. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243:268-275 (Pubitemid 46579719)
40. Rosenthal DI. Radiofrequency treatment. Orthop Clin North Am. 2006;37:475-84, viii.
41. Sans N, Galy-Fourcade D, Assoun J, Jarlaud T, Chiavassa H, Bonnevialle P, Railhac N, Giron J, Morera-Maupomé H, Railhac JJ. Osteoid osteoma: CT-guided percutaneous resection and follow-up in 38 patients. Radiology. 1999;212:687-692 (Pubitemid 29410968)
42. Woertler K, Vestring T, Boettner F, Winkelmann W, Heindel W, Lindner N. Osteoid osteoma: CT-guided percutaneous radiofrequency ablation and follow-up in 47 patients. J Vasc Interv Radiol. 2001;12:717-722 (Pubitemid 32521160)
43. Rosenthal DI, Alexander A, Rosenberg AE, Springfield D. Ablation of osteoid osteomas with a percutaneously placed electrode: a new procedure. Radiology. 1992;183:29-33.
44. Dupuy DE, Hong R, Oliver B, Goldberg SN. Radiofrequency ablation of spinal tumors: temperature distribution in the spinal canal. AJR Am J Roentgenol. 2000;175:1263-1266 (Pubitemid 30807144)
45. Callstrom MR, Charboneau JW, Goetz MP, Rubin J, Wong GY, Sloan JA, Novotny PJ, Lewis BD, Welch TJ, Farrell MA, Maus TP, Lee RA, Reading CC, Petersen IA, Pickett DD. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology. 2002;224:87-97. (Pubitemid 34680379)
46. Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP, Welch TJ, Wong GY, Sloan JA, Novotny PJ, Petersen IA, Beres RA, Regge D, Capanna R, Saker MB, Grönemeyer DH, Gevargez A, Ahrar K, Choti MA, de Baere TJ, Rubin J. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004;22:300-306 (Pubitemid 41095095)
47. Callstrom MR, Charboneau JW, Goetz MP, Rubin J, Atwell TD, Farrell MA, Welch TJ, Maus TP. Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol. 2006;35:1-15. (Pubitemid 43124377)
48. Gage AA. History of cryosurgery. Semin Surg Oncol. 1998;14:99-109.
49. Gage AA, Gonder MJ, Soanes WA, Emmings FG. Cancer cryotherapy. Mil Med. 1967;132:550-556
50. Sewell PE, Howard JC, Shingleton WB, Harrison RB. Interventional magnetic resonance image-guided percutaneous cryoablation of renal tumors. South Med J. 2003;96:708-710
51. Shingleton WB, Sewell PE Jr. Cryoablation of renal tumours in patients with solitary kidneys. BJU Int. 2003;92:237-239
52. Zhou XD, Tang ZY. Cryotherapy for primary liver cancer. Semin Surg Oncol. 1998;14:171-174
53. Callstrom MR, Charboneau JW. Technologies for ablation of hepatocellular carcinoma. Gastroenterology. 2008;134:1831-1835
54. Desai MM, Gill IS. Current status of cryoablation and radiofrequency ablation in the management of renal tumors. Curr Opin Urol. 2002;12:387-393
55. Sewell PE Jr, Jackson MS, Dhillon GS. Percutaneous MRI guided cryosurgery of bone tumors [abstract]. Radiology. 2002;225 Suppl:514.
56. Cotten A, Deprez X, Migaud H, Chabanne B, Duquesnoy B, Chastanet P. Malignant acetabular osteolyses: percutaneous injection of acrylic bone cement. Radiology. 1995;197:307-310
57. Kelekis A, Lovblad KO, Mehdizade A, Somon T, Yilmaz H, Wetzel SG, Seium Y, Dietrich PY, Rufenacht DA, Martin JB. Pelvic osteoplasty in osteolytic metastases: technical approach under fluoroscopic guidance and early clinical results. J Vasc Interv Radiol. 2005;16:81-88 (Pubitemid 40096508)
58. Schaefer O, Lohrmann C, Herling M, Uhrmeister P, Langer M. Combined radiofrequency thermal ablation and percutaneous cementoplasty treatment of a pathologic fracture. J Vasc Interv Radiol. 2002;13:1047-1050 (Pubitemid 35231863)
59. Marcy PY, Palussière J, Descamps B, Magné N, Bondiau PY, Ciais C, Bruneton JN. Percutaneous cementoplasty for pelvic bone metastasis. Support Care Cancer. 2000;8:500-3. Erratum in: Support Care Cancer. 2000;8:510. (Pubitemid 30823681)
60. Toyota N, Naito A, Kakizawa H, Hieda M, Hirai N, Tachikake T, Kimura T, Fukuda H, Ito K. Radiofrequency ablation therapy combined with cementoplasty for painful bone metastases: initial experience. Cardiovasc Intervent Radiol. 2005;28:578-583 (Pubitemid 41367564)
61. Nakatsuka A, Yamakado K, Maeda M, Yasuda M, Akeboshi M, Takaki H, Hamada A, Takeda K. Radiofrequency ablation combined with bone cement injection for the treatment of bone malignancies. J Vasc Interv Radiol. 2004;15:707-712 (Pubitemid 38880308)
62. Ecker RD, Endo T, Wetjen NM, Krauss WE. Diagnosis and treatment of vertebral column metastases. Mayo Clin Proc. 2005;80:1177-1186 (Pubitemid 41233355)
63. Hosono N, Ueda T, Tamura D, Aoki Y, Yoshikawa H. Prognostic relevance of clinical symptoms in patients with spinal metastases. Clin Orthop Relat Res. 2005;436:196-201. (Pubitemid 40961048)
64. North RB, LaRocca VR, Schwartz J, North CA, Zahurak M, Davis RF, McAfee PC. Surgical management of spinal metastases: analysis of prognostic factors during a 10-year experience. J Neurosurg Spine. 2005;2:564-573
65. Asdourian PL, Weidenbaum M, DeWald RL, Hammerberg KW, Ramsey RG. The pattern of vertebral involvement in metastatic vertebral breast cancer. Clin Orthop Relat Res. 1990;250:164-170 (Pubitemid 20033978)
66. Taneichi H, Kaneda K, Takeda N, Abumi K, Satoh S. Risk factors and probability of vertebral body collapse in metastases of the thoracic and lumbar spine. Spine. 1997;22:239-245 (Pubitemid 27085858)
67. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine. 2001;26:298-306.
68. Walker MP, Yaszemski MJ, Kim CW, Talac R, Currier BL. Metastatic disease of the spine: evaluation and treatment. Clin Orthop Relat Res. 2003;415 Suppl:S165-75.
69. Sundaresan N, Rothman A, Manhart K, Kelliher K. Surgery for solitary metastases of the spine: rationale and results of treatment. Spine. 2002;27:1802-1806 (Pubitemid 34894378)
70. Wai EK, Finkelstein JA, Tangente RP, Holden L, Chow E, Ford M, Yee A. Quality of life in surgical treatment of metastatic spine disease. Spine. 2003;28:508-512 (Pubitemid 36330842)
71. Klimo P Jr, Thompson CJ, Kestle JR, Schmidt MH. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro Oncol. 2005;7:64-76.
72. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366:643-648 (Pubitemid 41176016)
73. Ghogawala Z, Mansfield FL, Borges LF. Spinal radiation before surgical decompression adversely affects outcomes of surgery for symptomatic metastatic spinal cord compression. Spine. 2001;26:818-824 (Pubitemid 32268388)
74. Wise JJ, Fischgrund JS, Herkowitz HN, Montgomery D, Kurz LT. Complication, survival rates, and risk factors of surgery for metastatic disease of the spine. Spine. 1999;24:1943-1951 (Pubitemid 29449314)